Hello and Let’s talk about Donald Trump’s threat to India. The US president yesterday demanded that India remove its ban on the export of the drug hydroxychloroquine and threatened retaliation if it did not. Subsequently, the Indian government agreed to release stocks of the drug. This raises many questions. What is a country’s priority during a crisis such as COVID-19? How do countries cooperate as a community to ensure that there are enough drugs for all during this time? What benefits does this drug hydroxychloroquine bring? We’ll talk about this and more but first here are some updates.
Articles: Latest
- How Modi has supported Adani’s global ambitions
- When Reliance lost out to a small trust in a Mumbai property tussle
- Judicial Death of Saibaba, English Prof From a Peasant Family
- Unemployment and Under-employment of India’s Youth
- Furore over Adani’s pitch to revamp Nairobi airport
- Govt’s New PPF Policy To Hit NRIs & Small Investors
- Why SEBI Chairperson Madhabi Buch Should Resign
- Adani’s Godda coal-power plant and Bangladesh: rule change on power exports benefits Modi’s ‘crony’
- Major creditors cop a severe haircut as Adani Group acquires bankrupt real-estate firm, Radius
- Ashwini Vaishnaw: Controversial Rise from Bureaucrat to Modi's Key Man
Featured Book: As Author
Loose Pages
Court Cases That Could Have Shaken India
- Publisher: Paranjoy
- 376 pages
- Published month:
- Buy from Amazon
Link of the recording of the 70-minute deposition on 14 February 2022 by Paranjoy Guha Thakurta to the Supreme Court-appointed committee headed by Justice (retired) R V Raveendran on allegations of misuse of the Israeli Pegasus spyware on Indian citizens: https://pegasus-india-investigation.in/depositions/paranjoy-guha-thakurta-statement/